Content · healthcare · Middle EastJul 202611 min read353 words

The B2B podcasts framework we install for every client for healthcare and life sciences in the Middle East

A repeatable, seven-part framework for running B2B podcasts as a system — the same one we use inside every Growth Broker engagement. Written for commercial leaders at healthtech, medtech, and life-sciences companies in the Middle East.

This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in the Middle East. In this market, Middle Eastern buyers reward in-person credibility, sovereign fit, and patient sequencing, so the way you install B2B podcasts has to be shaped to that reality from day one.

We have installed B2B podcasts inside more than fifty companies. This is the framework we reach for every time. B2B podcasts is using a show to earn access to buyers who would ignore a cold email, and the framework exists to keep that definition honest under real conditions.

Part one, diagnosis. Before you touch the model, name the constraint: finance, demand, access, or conversion. B2B podcasts applied to the wrong constraint is theatre.

Part two, target. Narrow to one industry, one role, one trigger. Every extra dimension halves conversion.

Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in the Middle East it is compounded by the fact that senior-relationship access, not product is what actually gates growth. B2B podcasts is only useful here when it is pointed at both constraints at once.

Part three, offer. What is the buyer's next step, and what makes it obvious? The offer, not the copy, is what carries.

Part four, engine. Tools, sequences, data. Buy the minimum you can operate; every extra tool is a future dependency.

Part five, operating rhythm. Monday plan, Friday review, weekly guest-to-opportunity conversion. Nothing about the model is left to memory.

Parts six and seven, learning and allocation. What did we learn last week; where does next week's dollar go. Once those two loops are live, B2B podcasts compounds and the framework stops being visible.

Concretely for healthcare and life sciences in the Middle East: the healthcare teams that install this get past procurement instead of dying in it, and one sovereign or family-office win in the Middle East justifies a full year of program spend. That is the reason it is worth installing B2B podcasts deliberately for this market rather than importing a playbook designed for somewhere else.

B2B podcastpodcast for lead genfounder podcastB2B podcast frameworkB2B podcast modelB2B podcast for healthcare and life sciencesB2B podcast in the Middle Easthealthcare and life sciences growth in the Middle East

Frequently asked questions

Content · healthcare · Middle East — answered

Does B2B podcasts work for healthcare and life sciences in the Middle East?
Yes — provided it is pointed at regulated-sale cycle length, not intent and adapted to the fact that in the Middle East, Middle Eastern buyers reward in-person credibility, sovereign fit, and patient sequencing. The healthcare teams that install this get past procurement instead of dying in it.
Do I need all seven parts to see results?
Diagnosis, target, and operating rhythm are the non-negotiables. The others can lag by weeks, not quarters.
How long does the framework take to install?
Six to twelve weeks depending on the state of the data and the size of the team.
Can I adapt the framework to my stack?
The framework is stack-agnostic. Tooling is part four and is the most swappable piece.
What is the biggest risk to the framework?
Optimising for downloads instead of relationships — usually because a stakeholder shortcuts diagnosis to get to spend.
What is the Middle East-specific pitfall when running B2B podcasts for healthcare?
Importing a playbook that was built for another market. In the Middle East, Middle Eastern buyers reward in-person credibility, sovereign fit, and patient sequencing — the install has to reflect that.

Growth Broker editorial

Filed under content · healthcare · middle east

Up next

AI for Growth: the complete 2026 guide for B2B companies

Read piece

Ready to broker your growth?

Book a Growth Call